![]() Early eptifibatide im-proves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrillin in acute myocardial infarction (INTAMI) pilot trial. Early vs late ad-ministration of glycoprotein IIb/IIIa Inhibitor in primary per-cutaneous coronary intervention of acute ST-segment elevation myocardial infarction A meta-analysis. Montalescot G, Borentain M, Payot L, et al. Administration of ebtifibatide during transfer for primary PCI in patients with STEMI: Effect on Pre-PCI TIMI. facilitated PCI in patients with ST elevation myocardial infarction. Early administra-tion of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: Result of the early ReoPro administration in myo-cardial infarction (ERAMI) trial. Gabriel HM, Oliveira JA, da Silva PC, et al. Early initiation of ebtifibatide in the emergency department before primary percutaneous coronary intervention for ST segment elevation myocardial infarction : Result of the Time to Intergrillin Therapy in Acute Myocardial infarction (TITAN)-TIMI 34 trial. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. Abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long term follow up. Montalescot G, Baragan P, Wittenberg O, et al. Mahmud E, Pajeshki B.,Salami A., Keramati S., Highlights 2004 Transcatheter Cardiovascular Therapeutics (CTC) Annual Meeting Clinical Implication. Patients who received eptifibatide > 90 minutes before first angiographic IRA during primary PCI achieved more appropriate TIMI flow as compare to that received eptifibatide < 90 minutes. Group 2 showed more frequent TIMI 2 flow (18.9% vs 5.1%, p = 0.036) but tend to have less frequent TIMI 0 flow (56.8 % vs 67.1%, p = 0.281).Ĭonclusion. There were no significant differences of TIMI 3 flow proportion after PCI between the groups (86.1% vs 83.8% for Group 1 and 2 respectively, p = 0.745). Of 116 consecutive STEMI patients who underwent primary PCI, 79 patients received ebtifibatide 90 minutes (Group 2) before first angiographic of IRA. This study was aimed to evaluated effect of eptifibatide administra-tion timing to TIMI grading flow in first angiographic IRA during primary PCI in patients with STEMI. Several stud -ies have shown that early administration of eptifibatide, which is given to patients with pain awitan of 3 hours. Optimal administration timing of Glicoprotein IIb/IIIa inhibitor in STEMI patients undergoing Primary PCI is controversial. The incidence of multivessel coronary artery disease (MVD) was lower in the E-ROSC group than in the L-ROSC group (16.7% versus 58.8%, P = 0.001).Collateral and TIMI flow were not associated with ease of resuscitation, but MVD may have a negative impact on resuscitation, especially in VF patients.Ĭollapse to resuscitation time Coronary angiography Resuscitation.Background. ![]() We included ACS patients who had CPA with ventricular fibrillation (VF) as an initial rhythm, were successfully resuscitated, underwent coronary angiography (CAG), had a culprit lesion, and were diagnosed with ACS (n = 58 age, 63.7 ± 12.0 years 93.1% male).We divided the 58 patients into two groups, an early ROSC group (ROSC ≤ 20 minutes: E-ROSC) and a late ROSC group (ROSC > 20 minutes: L-ROSC), and then analyzed their characteristics.The finding of a collateral artery for the culprit lesion location, Rentrop II-III, and TIMI III flow on CAG on arrival presented no significant differences between the two groups (Rentrop II-III: 25.0% versus 23.5%, P = 0.90 TIMI III: 33.3% versus 35.3%, P = 0.88). ![]() Hence, we investigated this relationship in ACS patients with OHCA.A cohort of 2779 patients was admitted to our emergency center due to cardiopulmonary arrest (CPA) between April 2011 and March 2015. The relationship between the findings from the study of coronary images and return of spontaneous circulation (ROSC) interval is still unknown. Acute coronary syndrome (ACS) is the major cause of out-of-hospital cardiac arrest (OHCA). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |